169 related articles for article (PubMed ID: 20688625)
41. Rationale for treatment and therapeutic options in Cushing's disease.
Stewart PM; Petersenn S
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23 Suppl 1():S15-22. PubMed ID: 20129190
[TBL] [Abstract][Full Text] [Related]
42. A lack of day-by-day variability in blood pressure in a Cushing's disease patient.
Eguchi K; Kurita H; Matsumoto E; Hashimoto M; Kario K
J Hum Hypertens; 2017 Sep; 31(9):602-603. PubMed ID: 28332512
[No Abstract] [Full Text] [Related]
43. Cushing's disease: a single centre's experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy.
Wilson PJ; Williams JR; Smee RI
J Clin Neurosci; 2014 Jan; 21(1):100-6. PubMed ID: 24074805
[TBL] [Abstract][Full Text] [Related]
44. Radiation-induced optic neuropathy: still no treatment.
Miller NR
Clin Exp Ophthalmol; 2004 Jun; 32(3):233-5. PubMed ID: 15180831
[No Abstract] [Full Text] [Related]
45. Radiation-induced optic neuropathy.
Sallet G; Kestelyn P
Bull Soc Belge Ophtalmol; 1992; 243():99-107. PubMed ID: 1302158
[TBL] [Abstract][Full Text] [Related]
46. Magnetic resonance imaging of radiation optic neuropathy.
Zimmerman CF; Schatz NJ; Glaser JS
Am J Ophthalmol; 1990 Oct; 110(4):389-94. PubMed ID: 2220973
[TBL] [Abstract][Full Text] [Related]
47. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
[TBL] [Abstract][Full Text] [Related]
48. Surgical management of Cushing's disease.
Dallapiazza RF; Oldfield EH; Jane JA
Pituitary; 2015 Apr; 18(2):211-6. PubMed ID: 25724315
[TBL] [Abstract][Full Text] [Related]
49. Visual loss despite anticoagulation in radiation-induced optic neuropathy.
Danesh-Meyer HV; Savino PJ; Sergott RC
Clin Exp Ophthalmol; 2004 Jun; 32(3):333-5. PubMed ID: 15180850
[TBL] [Abstract][Full Text] [Related]
50. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors.
Parsons JT; Bova FJ; Fitzgerald CR; Mendenhall WM; Million RR
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):755-63. PubMed ID: 7960976
[TBL] [Abstract][Full Text] [Related]
51. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.
Harris JR; Levene MB
Radiology; 1976 Jul; 120(1):167-71. PubMed ID: 935443
[TBL] [Abstract][Full Text] [Related]
52. The effects of hyperbaric oxygen on visual functions in ischaemic optic neuropathy.
Bojić L; Kovacević H; Andrić D; Karaman-Kraljević K; Cagalj S
Arh Hig Rada Toksikol; 1994 Mar; 45(1):19-24. PubMed ID: 8067909
[TBL] [Abstract][Full Text] [Related]
53. Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
Kurowska M; Tarach JS; Malicka J; Zieliński G; Maksymowicz M; Denew P
Endokrynol Pol; 2016; 67(5):526-533. PubMed ID: 27828691
[TBL] [Abstract][Full Text] [Related]
54. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma.
Zhao Z; Lan Y; Bai S; Shen J; Xiao S; Lv R; Zhang B; Tao E; Liu J
J Clin Neurosci; 2013 May; 20(5):702-6. PubMed ID: 23317755
[TBL] [Abstract][Full Text] [Related]
55. Benefit of hyperbaric oxygen therapy treatment in direct traumatic optic neuropathy: case report.
Hsieh YH; Liang CM; Tai MC; Chen YJ
Undersea Hyperb Med; 2018; 45(4):463-471. PubMed ID: 30241127
[TBL] [Abstract][Full Text] [Related]
56. Radiation-induced optic neuropathy: a magnetic resonance imaging study.
Guy J; Mancuso A; Beck R; Moster ML; Sedwick LA; Quisling RG; Rhoton AL; Protzko EE; Schiffman J
J Neurosurg; 1991 Mar; 74(3):426-32. PubMed ID: 1993908
[TBL] [Abstract][Full Text] [Related]
57. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
Woo YS; Isidori AM; Wat WZ; Kaltsas GA; Afshar F; Sabin I; Jenkins PJ; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
[TBL] [Abstract][Full Text] [Related]
58. Giant pituitary macroadenoma at the age of 4 months: case report and review of the literature.
Siddiqui AA; Bashir SH
Childs Nerv Syst; 2006 Mar; 22(3):290-4. PubMed ID: 16047217
[TBL] [Abstract][Full Text] [Related]
59. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
60. Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma.
Donofrio CA; Losa M; Gemma M; Giudice L; Barzaghi LR; Mortini P
Endocrine; 2017 Nov; 58(2):303-311. PubMed ID: 28005257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
